Naiem T. Issa, MD, PhD, FAAD
Board-Certified Dermatologist
While my patients’ skin conditions may be similar, their journey through healing is unique to each one and requires a unique relationship. I take pride in establishing these relationships and providing my patients with what I like to call their ‘journey through care’. To me, patients are not simply seeking care for their condition, but looking for a partner to expertly guide them.
- Naiem T. Issa, MD, PhD

Undergraduate Degree:

Georgetown University, Washington, D.C.

Medical School:

Georgetown University, Washington, D.C.


Georgetown University, Washington, D.C.

PostDoctoral Research Associate:

University of Miami School of Medicine, Miami, FL

Dermatology Residency:

University of Miami Jackson Memorial Hospital Miami, FL

American Board of Dermatology
Professional Memberships
American Physician Scientist Association (APSA)
American Academy of Dermatology (AAD)
International Society of Dermatology (ISD)
Wound Healing Society (WHS)
American Hair Research Society (AHRS)
Howard Hughes Medical Institute (HHMI) Undergraduate Research Scholar
Best Thesis Presentation in the Department of Biology, Georgetown University
Clifford C. Kaslow Research Achievement Award for Basic Science Research, Georgetown University Department of Medicine
American Association for the Advancement of Science Program for Excellence in Science
Best Poster Award, 1st International Congress on Systems and Complexity in Health, Washington DC
TD Bank Basic Science Research Award, Georgetown University Department of Medicine
International Society of Dermatology (ISD) Global Education Award
Rising Derm Stars® Competition for Residents, Las Vegas, NV
  • Issa N.T., Kaiser M., Martinez‐Velasco A., Tosti A. Alopecia After Cosmetic Injection Procedures: A Review. Dermatol Surg. 2022 Jun 1. doi: 0.1097/DSS.0000000000003498. Epub ahead of print. PMID: 35642921.
  •  Issa, N.T., Wathieu, H., Glasgow, E., Peran, I., Parasido, E., Li, T., Simbulan‐Rosenthal, C.M., Rosenthal, D., Medvedev, A.V., Makarov, S.S., Albanese, C., Byers, S.W., Dakshanamurthy, S. (2022). A novel chemo‐phenotypic method identifies mixtures of salpn, vitamin D3, and pesticides involved in the development of colorectal and pancreatic cancer. Ecotoxicol Environ Saf.
  • Quinonez, R.L., Issa, N.T., Miteva, M. (2021). A case of ill‐defined erythematous plaques scattered on the scalp. Skin Appendage Disord. doi: 10.1159/000517803.
  • Chen, V., Issa, N.T., Bellodi Schmidt, F. (2021). Mosaic TP63 variant and associated ectodermal dysplasia features ‐ a case report. JAAD Case Rep. doi:10.1016/j.jdcr.2021.09.016.
  • Essegian, D.J., Issa, N.T., Nichols, A., Milicowski, C. (2021). Rare Presentation of the Generalized Papular Variant of Elastolytic Giant Cell Granuloma (EGCG) Associated with Follicular Lymphoma. JAAD Case Rep. doi:10.1016/j.jdcr.2021.08.020.
  • Issa, N.T., Tosti, A. (2021). Trichoscopy for the Hair Transplant Surgeon – Assessing for Mimickers of Androgenetic Alopecia and Pre‐Operative Evaluation of Donor Site Area. Indian Journal of Plastic Surgery.
  • Egger, E., Issa, N., Kirsner, R.S., Romanelli, P., Issa, N.T. (2020). A rare association of bullous pemphigoid with mycosis fungoides and Sézary syndrome. JAAD Case Rep.
  • Issa, N.T., Stathias V., Schürer, S., Dakshanamurthy, S. (2020). Machine and deep learning approaches for cancer drug repurposing. Semin Cancer Biol, pii: S1044‐579X(19)30409‐2. doi: 10.1016/j.semcancer.2019.12.011.
  • Bray, E.R., Kirsner, R.S., Issa, N.T. (2019). Coffee and skin – considerations beyond the caffeine perspective. J Am Acad Dermatol, 2(2):e63. doi: 10.1016/j.jaad.2019.10.022.
  • Issa, N.T., Badiavas, E.V., Schürer, S. (2019). Research Techniques Made Simple: Molecular docking in dermatology – a foray into in silico drug discovery. J Invest Dermatol, 139(12):2400‐ 2408.e1. doi: 10.1016/j.jid.2019.06.129.
  • Maimouni, S., Issa, N.T., Cheng, S., Cheema, A., Deepak, K., Byers, S. (2018). Tumor suppressor RARRES1‐ a novel regulator of fatty acid metabolism in epithelial cells. PLoS One, 13(12):e0208756. doi: 10.1371/journal.pone.0208756.
  • Wathieu, H., Issa, N.T., Fernandez, A.I., Mohandoss, M., Tiek, D.M., Franke, J.L., Byers, S.W., Riggins, R.B., Dakshanamurthy, S. (2017). Differential prioritization of therapies to subtypes of triple negative breast cancer using a systems medicine method. Oncotarget, 8(54), 92926‐42. doi:10.18632/oncotarget.21669
  • Yan, D., Issa, N.T., Afifi, L., Jeon, C., Chang, H.A., Liao, W. (2017). The role of the skin and gut microbiome in psoriatic disease. Curr Dermatol Rep, 6(2), 94‐103. doi:10.1007/s13671‐017‐0178‐ 5
  • Issa, N.T., Wathieu, H., Ojo, A., Byers, S.W., Dakshanamurthy, S. (2017). Drug metabolism in preclinical drug development: a survey of the discovery process, toxicology, and computational tools. Curr Drug Metab, 18(6), 556‐565. doi:10.2174/1389200218666170316093301.
  • Wathieu, H., Issa, N.T., Mohandoss, M., Byers, S.W., Dakshanamurthy, S. (2016). MSD‐MAP: A Network‐ Based Systems Biology Platform for Predicting Disease‐Metabolite Links. Comb Chem High Throughput Screen. doi: 10.2174/1386207319666161214111254.
  • Issa, N.T., Kruger, J., Wathieu, H., Raja, R., Byers, S.W., Dakshanamurthy, S. (2016). DrugGenEx‐ Net: A Novel Computational Platform for Systems Pharmacology and Gene Expression‐Based Drug Repurposing. BMC Bioinformatics, 17(1),202. doi: 10.1186/s12859‐016‐1065‐y.
  • Wathieu, H., Issa, N.T., Byers  S.W., Dakshanamurthy, S. (2016). Harnessing Polypharmacology with Computer‐Aided Drug Design and Systems Biology. Curr Pharm Des, 22(1):3097‐108.
  • Issa, N.T., Peters, O.J., Byers, S.W., Dakshanamurthy, S. (2015). RepurposeVS: A Drug Repurposing‐ Focused Computational Method for Accurate Drug‐Target Signature Predictions. Comb Chem High Throughput Screen, 18(1). doi: 10.2174/1386207318666150803130138.
  • Issa, N.T., Byers, S.W., Dakshanamurthy, S. (2014). Big Data: the next frontier for innovation in therapeutics and healthcare. Expert Rev Clin Pharmacol, 7(3):293‐8.
  • Issa, N.T., Byers, S.W., Dakshanamurthy, S. (2013). Drug Repurposing: Translational Pharmacology, Chemistry, Computers and the Clinic. Cur Topics in Med Chem, 13:2328‐36.
  • Issa, N.T., Kruger, J., Byers, S.W., Dakshanamurthy, S. (2013). At the Interface of Cancer Metabolomics and Therapeutics: A Drug Repurposing Opportunity. Metabolomics, S1: e002.
  • Issa, N.T., Kruger, J., Byers, S.W., Dakshanamurthy, S. (2013). Drug repurposing a reality: from
    computers to the clinic. Expert Rev Clin Pharmacol, 6(2):95‐7. doi: 10.1586/ecp.12.79.
  • Dakshanamurthy, S., Issa, N.T., Assefina, S., Seshasayee, A., Peters, O.J., Madhavan, S., Uren, A.,
    Brown, M.L., Byers, S.W. (2012). Predicting new indications for approved drugs using

*Age Restriction

For patients scheduling who are under 18 years of age (19 in Alabama) please make sure you have permission from your parent or legal guardian to schedule this appointment.  Your parent or legal guardian must accompany you on your initial visit and on certain subsequent visits to provide appropriate informed consent.